Proteinuria: Clinical Signficance and Basis for Therapy

作者: K T Woo , Y K Lau

DOI:

关键词:

摘要: Proteinuria is the hallmark of renal disease and proteinuria exceeding 1 gm a day in patients with augers poorer prognosis. has been shown to be tubulotoxic directly contributes deterioration. Patients non-selective are more likely have progressive disease. Diabetic persistent microhaematuria about 20 times risk developing diabetic nephropathy. In essential hypertension, onset de novo after years adequate BP control marker subsequent decline function. glomerulonephritis, severe associated faster rate progression. Even though initial phase glomerulonephritis usually immunological origin, vast majority established disease, latter proteinuric glomerulopathy result glomerular hyperfiltration which shifts pores larger dimensions resulting excessive leakage protein urine. Endothelial injury from causes increase local generation Angiotensin II kidney as part hemodynamic response. ACE inhibitors angiotensin receptor antagonists (ATRA) can improve pore-selectivity by remodelling basement membrane. addition, these agents also beneficial effects decreasing TGF-beta production therapy mesangial cell proliferation, hence ameliorating progression nephropathy IgA A number recent clinical trials that ACEI ATRA retard deterioration NIDDM those even restore normal function mild impairment. Treatment should regarded important treatment hypertension it prevent failure.

参考文章(29)
Bohle A, Wehrmann M, Kokot F, Mackensen-Haen S, Christensen J, Kendziorra H, The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clinical Nephrology. ,vol. 37, pp. 70- 77 ,(1992)
H Kitamura, K Yokoyama, E Imai, T Moriyama, M Izumi, A Yamauchi, N Ueda, S Ochi, T Kamada, Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. Journal of The American Society of Nephrology. ,vol. 6, pp. 1676- 1678 ,(1995) , 10.1681/ASN.V661676
Giuseppe Remuzzi, Piero Ruggenenti, Ariela Benigni, Understanding the nature of renal disease progression Kidney International. ,vol. 51, pp. 2- 15 ,(1997) , 10.1038/KI.1997.2
K. T. Woo, Protein Selectivity: A Prognostic Index in IgA Nephritis Nephron. ,vol. 52, pp. 300- 306 ,(1989) , 10.1159/000185667
Andrea Remuzzi, Elena Perticucci, Piero Ruggenenti, Lidia Mosconi, Marcello Limonta, Giuseppe Remuzzi, Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy Kidney International. ,vol. 39, pp. 1267- 1273 ,(1991) , 10.1038/KI.1991.160
J.Stewart Cameron, David R. Turner, Juliet Heaton, D.Gwyn Williams, Chisholm S. Ogg, Cyril Chantler, George B. Haycock, Jackie Hicks, Idiopathic mesangiocapillary glomerulonephritis The American Journal of Medicine. ,vol. 74, pp. 175- 192 ,(1983) , 10.1016/0002-9343(83)90606-X
Marta Ruiz-Ortega, Silvia González, Daniel Serón, Enric Condom, Carmen Bustos, Raquel Largo, Eva González, Alberto Ortiz, Jesus Egido, ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis Kidney International. ,vol. 48, pp. 1778- 1791 ,(1995) , 10.1038/KI.1995.476
H Yoshida, T Mitarai, T Kawamura, T Kitajima, Y Miyazaki, R Nagasawa, Y Kawaguchi, H Kubo, I Ichikawa, O Sakai, Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. Journal of Clinical Investigation. ,vol. 96, pp. 2162- 2169 ,(1995) , 10.1172/JCI118270
Andrea Remuzzi, Mathematical description of transport of water and macromolecules through the glomerular capillary wall. Current Opinion in Nephrology and Hypertension. ,vol. 4, pp. 343- 348 ,(1995) , 10.1097/00041552-199507000-00010